Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy (how well the drug works; primarily
through the time to relapse) of long-acting injectable paliperidone palmitate compared to
treatment as usual with orally administered antipsychotics in monotherapy over 24 months in
the treatment of recently diagnosed (1-5 years since diagnosis) schizophrenia.